Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | +4.35% | +4.35% | +4.35% |
Mar. 26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
Mar. 20 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.35% | 78.55M | |
+1.98% | 42.59B | |
+8.50% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.80% | 24.81B | |
-24.31% | 18.17B | |
+28.83% | 12.05B | |
-2.98% | 11.7B | |
+6.91% | 11.1B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- SUDA Pharmaceuticals : Acquires License for Cancer Cell Therapy Platform from UK Institution